Human Genome Project 2: Mapping the Genetics of One Percent of Humanity

The Legacy of the Human Genome Project and the Need for HGP-2

The completion of the Human Genome Project (HGP = Human Genom Project) in 2003 marked a milestone in mapping the human genome. Through this project, scientists opened the door to profound changes in health and society. Genetic research helped improve understanding of diseases, accelerate diagnosis, and personalize treatments. However, these advances have not yet reached everyone equally. As genomic technologies continue to develop, access remains unequal worldwide. This is where the Human Genome Project II (HGP-2) comes in. By aiming to sequence the genomes of 1% of humanity, HGP-2 seeks to better understand genetic diversity and use that knowledge to benefit public health.

Terms That Became Integral to Medicine with the Human Genome Project

• Precision medicine is a healthcare approach that considers individual differences in genomic, environmental, and lifestyle characteristics. It aims to tailor medical treatment and prevention strategies to the specific characteristics of an individual or a group. This differs from the traditional “one-size-fits-all” model, in which treatment and prevention strategies are developed according to population averages.
• Precision public health (precision public health) applies the principles of precision medicine to public health. It uses advanced technologies, data analysis, and interventions to prevent disease, promote health, and improve healthcare delivery. It aims to identify and target interventions for vulnerable or disadvantaged groups or individuals at higher risk of disease or poor health outcomes, maximizing the effectiveness and efficiency of public health efforts.
• Health span refers to the period of a person's life spent generally healthy and free from serious disease or chronic conditions. While lifespan refers simply to the total length of an individual's life, health span focuses on the time lived in good health and well-being. Preserving and extending health span is a primary aim of public health efforts, medical interventions, and lifestyle choices intended to promote healthy aging and reduce the burden of chronic disease and disability in older populations. Improving health span allows people to live longer, healthier, and more fulfilling lives.

The Public Health Impact of Genomics: Why Do We Need HGP-2?

The launch of HGP-2 was urged in a call issued by scientists on September 11, 2024 . The call highlights the importance of precision medicine and precision public health. Precision medicine enables treatments to be tailored to individuals' genomic, environmental, and lifestyle characteristics. Precision public health, in contrast, aims to maximize the impact of healthcare by identifying interventions for the most vulnerable groups across society. These two approaches allow individuals to live longer and healthier lives by extending their health span.

However, most current genomic research is concentrated in wealthy countries, preventing low- and middle-income countries from benefiting adequately from genomic technologies. By ensuring better representation of humanity's genetic heritage, HGP-2 offers a global framework for achieving health equity.

Making Genetic Diversity and Precision Medicine a Global Goal

One of the greatest limitations of genetic research is its reliance on data from restricted population samples that do not fully reflect genetic diversity. For example, the genomes mapped in the initial phase of HGP mostly came from samples obtained from populations of Western origin. Yet the genetic diversity of the world's population represents a much broader spectrum. This gap creates a risk that some genetic variations will remain undiscovered or be misinterpreted. HGP-2 aims to sequence the genomes of 80 million people from more than 100 countries and turn this diversity into a global pangenome reference.

RELATED TOPICS:

• What Is the Human Genome Project? Could It Be the Greatest Investment in Humanity?
• What Is The Cancer Genome Atlas? Its History and Important Milestones

HGP-2 Goals and Roadmap

Three main goals have been set for the first phase of HGP-2: data generation, precision intervention strategies, and integration into clinical practice.

1. Data Generation:

   • Sequence the genomes of 1% of the world's population (approximately 80 million people) and include their genetic diversity in the pangenome project.
   • Obtain 50,000 telomere-to-telomere reference genomes from more than 20 countries. “50,000 telomere-to-telomere reference genomes” means genomes sequenced completely from beginning to end. Telomeres are regions at the ends of chromosomes that play an important role in protecting genetic material. Genome sequencing means reading genetic information in full. Some earlier sequencing techniques, however, could skip or fail to read certain genomic regions completely.
   • Include environmental and lifestyle data alongside genetic data to create multi-omics datasets.

2. Precision Intervention Strategies:

   • Identify best practices for carrier screening, rare disease diagnosis, and pharmacogenetic interventions.
   • Report and act on clinically meaningful genetic findings.
   • Conduct health economics studies to assess the cost-effectiveness of genome-guided treatments.

3. Integration into Clinical Practice:

   • Interpret all genetic and multi-omics variations in a clinical context.
   • Integrate these findings into standard clinical practice and precision public health policies.

Overcoming Global Challenges: Economics, Organization, and Infrastructure

Several major global challenges must be overcome for HGP-2 to succeed. Economic inequalities give wealthy countries easier access to genomic technologies while low-income countries fall behind, increasing health inequality. HGP-2 plans to establish a funding mechanism that enables low- and middle-income countries to participate and facilitates access to these technologies.

Organizationally, HGP-2 needs to promote better cooperation among national initiatives. Differences between countries may create variation in implementing such projects. Establishing international standards and sharing best practices will therefore allow participating countries to work more efficiently.

Conclusion: A New Era in Access to Humanity's Genetic Knowledge

The launch of HGP-2 aims to represent a broader range of human genomes and make genomic technologies equally available to all humanity. Completing this project will help people worldwide live healthier and longer lives. It will also lay a strong foundation for the future of genetic research, revolutionizing many areas from disease prevention to treatment. HGP-2 may begin by targeting just 1%, but the effort opens the door to a future in which all humanity benefits from genetic knowledge.